A new oral treatment for psoriatic arthritis, Celgene's Otezla, has been approved in the US. Otezla (apremilast) is Celgene's attempt to break into the immunology field currently dominated by the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback